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The ribosomal proteins (RPs) form the majority of cellular proteins and are mandatory for cellular growth. RP genes have been
linked, either directly or indirectly, to various diseases in humans. Mutations in RP genes are also associated with tissue-
specific phenotypes, suggesting a possible role in organ development during early embryogenesis. However, it is not yet
known how mutations in a particular RP gene result in specific cellular changes, or how RP genes might contribute to human
diseases. The development of animal models with defects in RP genes will be essential for studying these questions. In this
study, we knocked down 21 RP genes in zebrafish by using morpholino antisense oligos to inhibit their translation. Of these 21,
knockdown of 19 RPs resulted in the development of morphants with obvious deformities. Although mutations in RP genes,
like other housekeeping genes, would be expected to result in nonspecific developmental defects with widespread
phenotypes, we found that knockdown of some RP genes resulted in phenotypes specific to each gene, with varying degrees
of abnormality in the brain, body trunk, eyes, and ears at about 25 hours post fertilization. We focused further on the
organogenesis of the brain. Each knocked-down gene that affected the morphogenesis of the brain produced a different
pattern of abnormality. Among the 7 RP genes whose knockdown produced severe brain phenotypes, 3 human orthologs are
located within chromosomal regions that have been linked to brain-associated diseases, suggesting a possible involvement of
RP genes in brain or neurological diseases. The RP gene knockdown system developed in this study could be a powerful tool
for studying the roles of ribosomes in human diseases.
Citation: Uechi T, Nakajima Y, Nakao A, Torihara H, Chakraborty A, et al. (2006) Ribosomal Protein Gene Knockdown Causes Developmental Defects in
Zebrafish. PLoS ONE 1(1): e37. doi:10.1371/journal.pone.0000037
INTRODUCTION
Ribosomes are large ribonucleoprotein particles that catalyze
messenger RNA-directed protein synthesis in all organisms.
Eukaryotic ribosomes are composed of four ribosomal RNA
(rRNA) species and about 79 different ribosomal proteins (RPs)
[1,2]. The higher-order structure of ribosomes has been well
studied in prokaryotes using high-resolution crystallography, and
the recent solution of co-crystals of ribosomes and other molecules,
including tRNA, mRNA, and proteins, by cryogenic electron
microscopy has improved our knowledge about the catalytic
activities of ribosomes [3]. Although these findings demonstrated
the central importance of rRNAs in ribosomes, and the structures
of RPs and their interactions with RNAs have been thoroughly
examined [4], the functions of RPs during translation have not
been fully investigated. Quantitative deficiencies of RP genes have
been suggested to contribute to the phenotype of the Minute
mutants of Drosophila, which are characterized by delayed
development; short, thin bristles; and recessive lethality; the RP
gene deficiencies lead to growth retardation of the mutants by
impairing the overall protein synthesis capacity of ribosome [5]. In
fact, more than 50 Minute loci scattered throughout the genome
have been found to encode RPs (S. Marygold, personal
communication).
Unlike the widespread abnormalities of the Minute fly mutants,
mutations in RP genes in mammals are associated with regional
abnormalities. One example are the Tail-short (Ts) mutants of
laboratory mouse strains; these mutants have short, kinky tails and
numerous skeletal abnormalities. Heterozygosity for the Ts locus
can be lethal, depending on the strain used for the cross, and the
locus controlling this dominant lethality has been mapped [6].
Further studies revealed that rpl38, which is located within this
locus, is altered in these mutants (T. Shiroishi, personal
communication). Similarly, a deletion within Rpl24 has been
identified in mouse ‘‘Belly spot and tail’’ (Bst) mutants, which show
a kinked tail, white hind feet, and a ventral midline spot [7]. For
both Rpl38 and Rpl24, expression of wild-type transgenes rescues
the abnormal phenotypes (T. Shiroishi, personal communication)
[7]. The only reported case of an RP gene mutation in human
disease is Diamond-Blackfan anemia (DBA; OMIM 105650):
RPS19 is heterozygously mutated in 25% of unrelated patients
with this disease [8,9]. However, neither the candidate genes in the
remaining 75% of the patients nor the role of RPS19 in
erythropoiesis has been fully investigated. Therefore, the patho-
genic mechanism of DBA remains unknown.
These reports suggest that RPs have unknown functions during
organogenesis. The development of animal models will be essential
for investigating these potential functions. Although Rps19
knockout mice (Rps19
2/2) have been developed [10], they are
not useful as a DBA model because Rps19
2/2 zygotes do not form
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+/2 mice show normal growth and
organ development, including development of the hematopoietic
system. It has been proposed that a regulatory mechanism
compensates for the loss of one Rps19 allele at the transcriptional
or translational levels in the Rps19
+/2 phenotypes, resulting in the
normalization of Rps19 function [10]. Therefore, we hypothesized
that the translational repression of RP mRNAs would be an
effective approach for studying the functions of RPs during organ
development. Zebrafish possess inherent advantages over other
animal models because the embryos develop rapidly and the fish
are easy to rear. Furthermore, morpholino antisense oligos (MOs)
have been widely used in zebrafish to block the initiation of
translation, and this method has proved to be highly reliable
[11,12]. In this study, we inhibited the translation of 20 RPs in
zebrafish using MOs specific to each gene and examined
morphogenesis in each of the embryos to investigate the usefulness
of this system for developing models of RP-associated diseases.
RESULTS
Development of RP Knockdown Fish Using MOs
A previous large-scale insertional mutagenesis screen in zebrafish
identified more than 500 mutants, including mutants for several
RP genes [13]. Therefore, the first step in our study was to
examine whether the injection of MOs specifically targeting RP
genes would result in embryonic phenotypes similar to those seen
in insertional RP mutants. Of the RP genes identified in the
insertional mutagenesis screen, we randomly selected the ribo-
somal protein L35 gene (rpl35) for the comparison and designed
a specific MO for this gene to conduct a pilot injection study.
Embryos injected with the MO against rpl35 mRNA had small
heads, round gray yolk sacs, and showed overall body de-
generation, similar to what was described for the insertional
mutant observed at 2 to 4 days post fertilization (dpf) [13]. Hence,
our preliminary results suggested that use of MOs could be an easy
and effective strategy to knock down RP genes. However, we
noticed that the general phenotypic features observed with rpl35
knockdown were common among the RP gene mutants at these
later stages of embryonic development (2–4 dpf), when morpho-
genesis of primary organs systems is complete. We therefore chose
to examine MO-injected embryos in more detail during the early
stages of embryonic development, at 23.5–28.5 hours post
injection when important organs such as brain, heart, and tail
begin to develop. We designed specific MOs for 21 RP genes,
chosen on the basis of previous studies suggesting their in-
volvement in developmental process of some organisms, and
carefully observed the morphants at about 25 hpf.
We injected each MO into 20 to 50 fertilized eggs. The MO-
injected embryos were compared to control embryos using a 24-
point data sheet that included details regarding the shape,
appearance, and morphology of various organs and overall
condition of the embryos. The images and phenotypic descriptions
of the embryos are available at the in-house database (http://
zebrafish.med.miyazaki-u.ac.jp). We observed consistent pheno-
types for each MO. A summary of common phenotypes observed
among all the morphants at 23.5–28.5 hpf is presented in Table 1
and representative images of the morphants are shown in Figure 1.
We also injected control MOs (misMOs) for the rps4, rps19, rpl24,
rpl35, and rpl38 genes (Table S1), and confirmed that the embryos
did not display any morphological changes when compared to
uninjected controls (see Figure 1, rpl38; misMO). We also
confirmed that the abnormal phenotypes were rescued by injecting
synthesized capped mRNA of rpl38 (Figure S1). Hypoplasia of the
yolk sac extension was evident in almost all the morphants except
for rpl5; MO117 and rplp1 (Figure 1). Cloudiness of the head
region, delayed pigmentation in the retina, abnormalities in the
ear, and reduction in melanophore pigments were observed in
most of the morphants (Table 1 and Figure 1). Shortening of the
body trunk was seen in the rps3a, rps4, rps29, rpl6, rpl28, rpl35,
rpl35a, and rpl38 morphants (Figure 1). Severely stagnant blood
cells resulting from circulatory defects were observed in the rps3a,
rps4, rps15, rps15a, rps19, rps29, rpl6, rpl28, rpl35, and rplp0
morphants (Figure 1). All the embryos exhibiting abnormal
phenotypes at 23.5–28.5 hpf died by 7–10 days post fertilization.
Deformation of the Brain and Body Trunk
The subdivisions of the developing brain can be identified under
a stereoscopic microscope in zebrafish embryos at about 25 hpf.
Abnormalities in the body trunk, including in circulation and
notochord formation, can also be observed easily at this stage. The
developmental defects in the brain and body trunk differed
depending on the RP gene knocked down (Figure 2). For example,
morphants of the rps15, rps29, and rpl28 genes consistently showed
an enlarged fourth ventricle (Figure 2B), undulated rhomben-
cephalon (Figure 2C), and protruding forehead (Figure 2D),
respectively. We also observed some distinct body trunk
deformities, such as a curved tail (rps3a, Figure 2F), twisted tail
(rps29, Figure 2G), or sharply bent tail (rp135a, Figure 2H).
To compare the brain and body trunk phenotypes in more
detail, we scored the extent of abnormality in 6 parts of the brain,
3 parts of the body trunk, and the dorsal view of the trunk
(Figure 3A) using a 3-level severity scale. The brain was most
affected in the morphants of the rps3, rps4, rps15a, rps29, rpl6,
rpl35a, and rplp0 genes (Figure 3B). Within the brain, the
telencephalon (Figure 3A-f) was much smaller than normal in
morphants of rps3a, rps4, rps15a, and rpl6, whereas aplasia of the
midbrain-hindbrain boundary (Figure 3A-c) was most prominent
in morphants of rps3, rps3a, rps4, rps29, rpl5mix, rpl6, and rpl35a.
The body trunk was extremely deformed in morphants of the rps3a
and rps29 genes. However, there was no correlation in the extent
of deformity between the brain and the body trunk in a given
morphant. For example, the brain was severely affected in rps15a
morphants, whereas the tail was only mildly affected. Conversely,
in the rps3a morphants, the brain exhibited only mild effects but
the body trunk showed extreme deformities (Figure 3B).
Disease Model
We evaluated the possibility of using RP knockdown fish as models
of human diseases. By searching the OMIM database (http://
www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM), we found
that some human orthologs of the RP genes we targeted in
zebrafish are located in chromosomal regions associated with
diseases. Therefore, the phenotypes of our zebrafish knockdowns
are likely to have some relevance to the clinical features of human
diseases. Using the uniSTS database (http://www.ncbi.nlm.nih.
gov/entrez/query.fcgi?db=unists), a comprehensive dataset of
sequence tagged sites (STSs) that represent unique genomic
positions on the human genome, we confirmed the positional
relationships between the RP genes and the markers of the
candidate chromosomal regions linked to disease. Our analysis
revealed that the human RPS4X, RPS15A, and RPLP0 genes are
located in chromosomal regions linked to brain or neurological
disorders (Table 2), and brain regions were affected in the
morphants for these genes. Among the neurological diseases
associated with the human genes, Abidi type X-linked mental
retardation (XLMR; OMIM 300262) [14] and microhydranence-
phaly (MHAC; OMIM 605013) [15] share some common
RP Gene Knockdown
PLoS ONE | www.plosone.org 2 December 2006 | Issue 1 | e37Figure 1. Lateral Views of Wild-Type and MO-Injected Embryos
The genes targeted by MOs and the observation time are indicated for each image. ‘rpl5; MO116’ and ‘rpl5; MO117’ indicate two MOs designed and
injected separately for two functional copies of rpl5 on the zebrafish genome. ‘rpl5; MOmix’ indicates the mixture of MO116 and MO117. Control MOs
that included 5 mispaired bases were also used; one example of a control MO injection is shown (rpl38; misMO). Note that compared to the control,
the rpl38 morphant is shorter and displays a light-colored eye and thin yolk sac extension. Scale bar, 500 mm.
doi:10.1371/journal.pone.0000037.g001
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PLoS ONE | www.plosone.org 3 December 2006 | Issue 1 | e37diagnostic features, such as shorter body, smaller head circumfer-
ence, and sloping forehead (Figure 4A). In our study, the
morphants of the rps4 and rps15a genes, which may be related to
Table 1. Summary of Phenotypes at About 25 hpf
......................................................................
Phenotype affected not affected
Head
Cloudy cells 16 6
Eye
Retina diameter 7 15
Lens diameter 4 18
Ear
Otic capsule major axis 18 4
Otoliths distance 16 6
Circulation 10 12
Yolk sac extension 20 2



























































Figure 2. Specific Morphological Changes in Brain and Body Trunk
Examples of morphants displaying characteristic deformations are
shown. The targeted genes and the deformed areas of the morphants
are indicated. (A, E) Wild type (WT). (B) rps15; enlarged 4th ventricle
(white arrow). (C) rps29; enlarged lens (arrowhead) and undulated
rhombencephalon (white arrow). (D) rpl28; protruded forehead. (F)
rps3a; wider trunk and downward-curving tail. (G) rps29; wavy
notochord and extremely bent tail. (H) rpl35a; sharply downward bent
tail. Anterior is to the left. Bars: A,D, 100 mm; E,H, 200 mm.
doi:10.1371/journal.pone.0000037.g002
Figure 3. Schematic Representation of the Extent of Abnormalities in
Brain and Body Trunk
(A) 6 parts of the brain, 3 parts of the body trunk, and a dorsal view of
the trunk are indicated in wild type embryo. a, optic tectum; b, 4th
ventricle; c, midbrain-hindbrain boundary; d, anterior part of head; e,
rhombencephalon; f, telencephalon; g, body along yolk sac extension;
h, tail; i, tip of tail; j, dorsal view of the trunk. (B) The deformations were
assessed using a 3-level severity scale; dark gray indicates a severe
effect, light gray indicates a mild effect, and white represents no
apparent effect. Detailed information and images of the abnormalities
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deformation of the telencephalon (Figure 4B), although these
two morphants displayed otherwise different patterns of brain
deformity (Figure 3B). The morphants of the rplp0 gene, whose
human ortholog is included in the candidate chromosomal region
of Charcot-Marie-Tooth disease type 2L (CMT2L, a type of
neuropathy; OMIM 608673), showed hypoplasia of the rhomb-




In recent years, the relationship between ribosomal components or
the ribosome itself and human diseases has received considerable
attention. For example, defects in maturation of the 40S subunit or
changes in level of RP gene expression may be associated with
bone marrow failure and cancer susceptibility syndromes in
humans [16,17]. However, the present knowledge about this
relationship is very limited and we have not yet understood
completely whether defects in the ribosome are a cause or
a consequence of such diseases. In our previous studies, we
mapped and sequenced the human RP genes systematically
[18,19], and identified certain genes that might be involved in
human disease based on a comparative analysis of their assigned
genomic positions with candidate regions for Mendelian disorders
[20]. To further understand this involvement, we needed to
develop an appropriate vertebrate model for systematically
studying the effects of ribosomal defects.
Here we developed a system in zebrafish using specifically
designed MOs to inhibit the translation of RP genes. Out of a total
of 79 RPs, we have so far developed morphants for 20 RPs. Some
RP gene mutants were previously isolated from zebrafish using
insertional mutagenesis [13,21]. Although this insertional screen-
ing was carried out on a large scale aimed at identifying genes
essential for early development, the phenotypic descriptions of
these insertional mutants were rather preliminary and most of the
images provided were taken at 2 to 4 dpf. In the current study, we
observed the phenotypes of the MO-mediated RP knockdown
embryos in more detail at 23.5–28.5 hpf and also examined the
defects in particular organs, especially the brain.
Our results show that it is easy to develop zebrafish with RP
defects that produce reproducible phenotypes using MOs as
knockdown agents. Since the loss-of-function effect of injected
MOs usually lasts for 2 to 4 days [12], such systems can be
efficiently used to study how disruption of RP gene translation
affects the early embryogenesis of vertebrates.
Implications for the Study of Human Disease
Many genes encoding factors involved in ribosome synthesis are
mutated in inherited bone marrow failure syndromes, including X-
linked dyskeratosis congenita, cartilage-hair hypoplasia, DBA, and
Shwachman-Diamond syndrome. In addition, several RP genes
have been identified as tumor suppressor genes in zebrafish [22].
Although it is not clear whether the association between ribosomal
defects and bone marrow failure is coincidental or causal, the
various theories supporting this association have been examined in
comprehensive reviews [16,17].
In this study, we mainly focused on morphological changes in
the brain regions of the morphants and on the possible association
of ribosomes with brain diseases. Our results suggest that some RP
genes might function in the morphogenesis of the zebrafish brain.
Intriguingly, human orthologs of 3 RP genes, that affected the
brain formation when knocked down, are included in the
candidate regions of the brain and neurological disorders
(Table 2). In humans, RPS4X is included in the chromosomal
region that is a candidate location for the gene that causes Abidi
type XLMR. Patients with the XLMR have short stature, small
heads with sloping foreheads, and a broad range of somatic
manifestations [14]. In this study, rps4 morphants displayed severe
Figure 4. Similarities between the Clinical Features of Human Brain
Diseases and Defects in Zebrafish Morphants
(A) Common features shared between Abidi X-linked mental retardation
and microhydranencephaly are listed on the left and the corresponding
changes in rps4 and rps15a morphants are indicated on the right. (B)
Telencephalon hypoplasia is seen in rps4 morphants, and reduction in
size and deformity of the telencephalon is apparent in rps15a
morphants (white arrows). Unclear subdivisions of the brain and
flattened foreheads (arrowheads) can be seen in lateral views of these
morphants.
doi:10.1371/journal.pone.0000037.g004
Table 2. The Candidate Chromosomal Regions Linked to Brain
Disease and the Human RP genes Included in These Regions
......................................................................
Disease Candidate region RP gene
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PLoS ONE | www.plosone.org 5 December 2006 | Issue 1 | e37deformities in the brain region, whereas the body trunk remained
relatively unaffected (Figures 3B and 4B). Roughly 40% of the
genes on the human X chromosome are expressed in the brain,
suggesting their possible involvement in mental retardation, and to
date 61 X-linked genes have been implicated in various types of
XLMR [23]. Therefore, RPS4X could also play an important role
in brain function. In CMT2L, an axonal neuropathy, the assigned
locus contains 26 candidate genes, including the RPLP0 gene. All
the known exons and splice sites of these identified genes have
been sequenced, and patient-specific mutations in HSPB8, which
encodes the 22-kDa heat shock protein 8, were identified [24].
However, mutations in HSPB8 have also been identified in
patients with distal hereditary motor type II (dHMN II; OMIM
158590) disease [25], which is a third type of CMT with
degradation of spinal cord anterior horn cells. Although it is still
unknown how mutations in HSPB8 cause these two different
diseases, other genes may act synergistically with HSPB8 to
produce different symptoms. Genome mapping analysis has
identified a locus for another type of Charcot-Marie-Tooth
disease, CMT2C (OMIM 606071), 10 Mb upstream of the
CMT2L locus, near the RPL6 gene. In this study, the both rplp0
and rpl6 morphants had severe brain deformities (see the database:
http://zebrafish.med.miyazaki-u.ac.jp and Figure 4B), indicating
a possible relationship between these RPs and neurological
disorders. The gene implicated in MHAC was localized to
a minimal critical region of 7.4 Mb of the chromosome 16 [15],
which includes the RPS15A gene. The phenotypic features of this
disease are severe mental and motor retardation, small body size,
and small occipital-frontal circumference without any other
obvious abnormalities [15]. The rps15a knockdown zebrafish also
showed striking features in the head, especially the telencephalon
(Figure 4B), whereas the body trunk did not display any obvious
abnormalities other than some mild effects on the tip of the tail
(Figure 3B). Hence, we speculate that RPS15A might play
a significant role in the pathogenicity of MHAC.
Indication of Specific Functions of RP Genes
Large-scale chemical mutagenesis screens in zebrafish led to the
identification of many mutants that displayed widespread,
apparently non-tissue-specific abnormalities [26,27]. It was
assumed that mutations in cell-essential or housekeeping genes
would have resulted in these general, frequently recurring mutants.
Insertional mutagenesis screening, which, unlike chemical muta-
genesis, enables efficient cloning of the disrupted genes, confirmed
that mutations in genes required for essential cellular functions
such as protein synthesis, RNA processing, DNA replication, and
chromatin assembly often result in nonspecific developmental
phenotypes. In contrast, lesions in genes encoding transcription
factors, receptors, and ligands tend to result in mutants with
specific developmental defects in one or a few organ systems [13].
Contrary to these findings, we found that inhibiting the
translation of some RP genes, which are typically considered
housekeeping genes, can give rise to specific changes in developing
embryos (Figures 1 and 2). For example, the degree of abnormality
within the brain subdivisions varied depending on which RP gene
was targeted (Figure 3B). Moreover, when we repressed the
expression of rps19, whose human ortholog is mutated in 25% of
DBA patients [9], and performed hemoglobin staining at 48 hpf,
the rps19 morphants stained poorly when compared to other RP
knockdown morphants, which could indicate a reduced red blood
cell count (data not shown). Therefore, we speculate that the
organs that display specific changes in response to RP knockdown
may have a high sensitivity to a particular RP insufficiency, and
this predictable sensitivity may be related to the specialized
translational activity of ribosomes in different cells or organs.
Another example that suggests a specific role for a housekeeping
gene is vanishing white matter disease (VWM; OMIM 603896).
VWM is a chronic neurological disorder, and mutations in any
one of the 5 genes encoding the subunits of eukaryotic translation
initiation factor 2B (eIF2B) produce symptoms that are consistent
with this disease. In most cases, the white matter of the brain, and
particularly the glia cells, is affected, whereas the neurons are
spared [28,29]. Accordingly, it is conceivable that alterations in
the expression of ubiquitous proteins such as RPs affect different
cells or organs differently. Moreover, if RPs are critical in shaping
the activity of the translational machinery, the activity of the
ribosome would vary between cells. To address this possibility,
a multifaceted approach is required, such as comprehensive
analyses of gene expression and histological analyses of organs.
The RP knockdown system developed in this study could be
a valuable tool for such analyses. Considering the highly conserved
nature of RP genes across vertebrate evolution, this knockdown




MOs were obtained from Gene Tools, LLC (Philomath, OR). The
MOs were designed within 22 bp upstream and 22 bp down-
stream of the translation start site (AUG) for 21 RP genes: rps3,
rps3a, rps4, rps8, rps15, rps15a, rps19, rps29, rpl5 (2 copies), rpl6,
rpl11, rpl24, rpl28, rpl35, rpl35a, rpl36a, rpl38, rplp0, rplp1, and rplp2.
Since 2 functional copies of rpl5 exist in the zebrafish genome, two
MOs (MO116 and MO117) were designed separately for each
copy. In addition, a mixture of these MOs was also used (rpl5;
MOmix). Control MOs with 5 mispaired bases were also obtained
for 5 RP genes: rps4, rps19, rpl24, rpl35, and rpl38. The sequences
of the MOs are shown in Table S1.
MO Injections
Zebrafish embryos at the one-cell stage were injected with the
MOs using an IM-30 Electric Microinjector (NARISHIGE,
Tokyo). Based on initial injection trials, 0.5 mg/ml (about
60 mM), was chosen as the optimal concentration for rps3, rps3a,
rps4, rps8, rps15, rps15a, rps19, rpl6, rpl11, rpl24, rpl35, rpl35a, rpl36a,
and rpl38, whereas 5.0 mg/ml (about 0.6 mM) was considered
optimal for rps29, rpl5 (both copies), rpl28, rplp0, rplp1, and rplp2.
Control MOs were injected at the optimal concentrations of their
corresponding MOs.
Observation of the Morphants and Database
Construction
The MO-injected or uninjected embryos were grown at 28.5uC
and observed for morphological changes under a stereoscopic
microscope at 23.5 to 28.5 hpf. We assessed abnormalities in the
shape, size, and morphology of the various organs in the
morphants using an original 24-point data sheet (available at
http://zebrafish.med.miyazaki-u.ac.jp). We also constructed a da-
tabase to compare and record the morphological changes
observed in the morphants for each RP gene. In addition to the
dataset assessments, we further examined the morphants for
specific abnormalities in 6 parts of the developing brain: optic
tectum, fourth ventricle, midbrain-hindbrain boundary, anterior
portion of the head, rhombencephalon, and telencephalon; 3 parts
of the body: lateral trunk, midsection of the tail, and tip of the tail;
RP Gene Knockdown
PLoS ONE | www.plosone.org 6 December 2006 | Issue 1 | e37and the dorsal view of the trunk. The extent of the deformities in
these selected body parts was recorded using a 3-level severity
scale. The eyes and ears of normal embryos ranged in size. For the
injected embryos, if the measured size of the eye or ear was outside
of the normal range, we considered these morphants to be affected
by the knockdown. Body length was measured along the
notochord from the posterior line of the otic capsule to the tip
of the tail.
SUPPORTING INFORMATION
Table S1 The Sequences of the Morpholino Antisense Oligos
Used in This Study
Found at: doi:10.1371/journal.pone.0000037.s001 (0.02 MB
PDF)
Figure S1 Rescued Embryos Co-Injected with the MO for rpl38
and Synthesized mRNA. Three days post fertilization embryos
injected with the rpl38MO (0.5 mg/ml) displaying smaller head,
shortened body and reduced yolk sac extension when compared to
the wild type embryos. These phenotypes are rescued by co-
injecting MO (0.5 mg/ml) and synthesized capped mRNA (0.5 mg/
ml) for rpl38 gene. The mRNA included altered bases that did not
bind with the MO. Scale bar, 500 mm. The sequence information
of the mRNA used for rescue is available at http://zebrafish.med.
miyazaki-u.ac.jp.
Found at: doi:10.1371/journal.pone.0000037.s002 (0.04 MB
PDF)
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